34 Teachers and Schools Across North America Receive $10,000 Amgen Award

AmgenAmgen (Nasdaq: AMGN) announced the 34 science teachers in the United States (U.S.), Canada and Puerto Rico who are this year's recipients of the 18th annual Amgen Award for Science Teaching Excellence. The award recognizes extraordinary teachers in grades K-12 whose dedication to students has had a significant impact on the learning and interest of the future generation of scientists.

Since the program's inception in 1992, Amgen has awarded more than $2.5 million to educators who have made exceptional science-teaching contributions and who have achieved demonstrated results in student learning in communities where Amgen operates. In 2010, Amgen received nearly 250 applications for the Amgen Award for Science Teaching Excellence and winners were honored at special ceremonies in their respective Amgen communities or during surprise presentations at their schools.

"Amgen believes in the enduring value of science education and is committed to supporting programs that encourage bright young minds to explore a future in science," said Joe Miletich, senior vice president of research and development at Amgen. "We applaud this year's award recipients for their dedication to delivering quality science education to tomorrow's innovators."

The 34 selected winners will receive the following benefits:

  • An unrestricted cash award of $5,000 USD or $5,000 CAD; and
  • A restricted $5,000 USD or $5,000 CAD cash grant to the recipient's school for the expansion or enhancement of a school science program, science resources, or the professional development of the school's science teachers;

Along with the award applications, teachers were asked to submit an innovative science lesson plan which had been successfully introduced in their classroom. Amgen will post select winning lesson plans to its Web site to promote the sharing of this knowledge with educators across the country to bolster excellence and innovation in science teaching.

Amgen partnered with the University of Wisconsin - Madison School of Education to judge the teaching awards in the U.S. and Puerto Rico. The School's Department of Curriculum and Instruction is consistently recognized as a leader in education, and their expertise aided in the selection of the strongest possible winners.

Nominations are solicited every fall with winners selected based on the following criteria: innovative science lesson plan, creativity and effectiveness of teaching methods; and the plan for the use of grant money to improve science education resources in their schools.

For more information about this year's winners and the program, please visit http://www.amgen.com/citizenship/aaste.html.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Most Popular Now

GSK reaches agreement with Novartis to acquire ful…

GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that it has reached an agreement with Novartis for the buyout of Novartis' 36.5% stake in their Consumer Healthcare Jo...

Canadian neuroscientists say daily ibuprofen can p…

A Vancouver-based research team led by Canada's most cited neuroscientist, Dr. Patrick McGeer, has successfully carried out studies suggesting that, if started early enou...

First proof a synthesized antibiotic is capable of…

A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time - and could lea...

Merck partners with Medisafe to help improve medic…

Merck, a leading science and technology company, today announced a new collaboration with US-based Medisafe to help its cardiometabolic patients better manage medication ...

Novartis teams up with Harvard to develop next gen…

Novartis announced today that it is teaming up with scientists from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Can...

Phase III data in The Lancet show Novartis siponim…

Novartis today announced that the full results from the Phase III EXPAND study of oral, once-daily siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS) w...

Taking a standard prostate cancer drug with food b…

By taking a high-cost drug with a low-fat meal - instead of on an empty stomach, as prescribed - prostate cancer patients could decrease their daily dose, prevent digesti...

North and south cooperation to combat tuberculosis

Tuberculosis can be cured and could be eradicated. For this to happen, however, patients have to receive the right treatment. Researchers at the Makerere University and t...

New immunotherapy for lung cancer shows promise of…

In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at contro...

Lokelma approved in the EU for the treatment of ad…

AstraZeneca today announced that the European Commission has granted marketing authorisation for Lokelma (formerly ZS-9, sodium zirconium cyclosilicate) for the treatment...

New targeted therapy schedule could keep melanoma …

Skin melanoma, a particularly insidious cancer, accounts for the vast majority skin cancer deaths and is one of the most common cancers in people under 30. Treatment for ...

Personalized tumor vaccine shows promise in pilot …

A new type of cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and...